Skip to main content

Eden Research to use Polish approval for Mevalone as springboard into central Europe

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive after announcing that the company's flagship bio-fungicide Mevalone has been approved for use by Polish regulators.

Smith says that the authorisation in Poland is just the beginning of a cascading process that will continue into adjacent European Union member states as well as the United Kingdom.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.01
-7.26 (-3.10%)
AAPL  275.15
-17.93 (-6.12%)
AMD  532.57
+12.83 (2.47%)
BAC  58.19
+0.46 (0.80%)
GOOG  342.19
-2.85 (-0.83%)
META  542.87
-14.80 (-2.65%)
MSFT  352.83
-12.63 (-3.46%)
NVDA  195.74
-3.26 (-1.64%)
ORCL  152.46
-5.07 (-3.22%)
TSLA  375.12
-0.41 (-0.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.